A5089704259- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Research
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Peripheral Neuropathies and Disorders
- Diabetes and associated disorders
- Multiple Sclerosis Research Studies
- Acute Lymphoblastic Leukemia research
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Cerebrospinal fluid and hydrocephalus
- Cancer Genomics and Diagnostics
- Neonatal Health and Biochemistry
- Epilepsy research and treatment
- Pharmacological Effects and Toxicity Studies
- Multiple Myeloma Research and Treatments
- Polyomavirus and related diseases
Policlinico S.Orsola-Malpighi
2020
University of Bologna
2020
University of Rome Tor Vergata
2010-2015
Serum and urine free light chains (FLCs) monoclonal immunoglobulin (k λ) are important markers in the diagnosis monitoring of B cell proliferative disorders, such as Multiple Myeloma (MM), Monoclonal Gammopathy (MG), Undetermined Significance (MGUS), Amyloidosis (AL) related disorders (Bird et al, 2009; Kyle 2010). MM is a progressive neoplastic disease characterized by bone marrow plasmacytosis (plasma tumour) overproduction an intact (IgG, IgA, IgM, IgD or IgE) and/or Bence Jones protein....